Publication | Open Access

The influence of palifermin (Kepivance) on oral mucositis and acute graft versus host disease in patients with hematological diseases undergoing hematopoietic stem cell transplant

InflammationCell TherapyTransplantationAutoimmune DiseaseStem Cell TransplantationImmunologyGraft RejectionImmunosuppressionOral MucositisImmunotherapyMedicineCell TransplantationHematological Diseases